Market Research Report
European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025
|Published by||Orion Market Research Pvt Ltd||Product code||947758|
Delivery time: 2-3 business days
|European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025|
|Published: March 27, 2020||Content info:||
European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
European digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.6% during the forecast period. Europe is considered as one of the major regions in the global dPCR and qPCR market. The market in Europe is driven by an increasing prevalence of chronic diseases such as cancer and CVDs. Government initiatives, programs and funding for cancer-related programs are also contributing to the rise in research activities for such chronic diseases, which in turn, is offering growth to the global dPCR and qPCR market in the region. In Europe, several key players are present which are contributing to the growth of the global dPCR and qPCR markets. This includes BioMerieux S.A., F. Hoffmann-La Roche AG, and QIAGEN N.V.
In Europe, thermophilic Campylobacter is one of the major bacterial food pathogens. Hygienic measures in the whole food chain, starting at primary production, are considered as the most effective tool to fight campylobacteriosis. Risk assessment is based on Campylobacter quantification by conventional microbiology. This methodology, however, is prone to underestimation of the infectious bacterial contamination as "viable, however, non-cultivable" Campylobacter is not detected. This problem affects several other foodborne pathogens. The application of dPCR may provide a step towards quantification in this important field.
Realizing the importance of dPCR and qPCR, the market players are regularly working in this field and updating their existing technologies. For instance, in January 2019, QIAGEN N.V. acquired FORMULATRIX digital PCR technology. QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN's focus in assay development and automation.
The market study of the European dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include::
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
The Report covers: